Editorial Commentary: End-Stage Liver Disease in HIV Infection: An Avoidable Burden?

Affiliations

¹ University of Bordeaux Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219- Bordeaux Population Health Centre Hospitalier Universitaire de Bordeaux, Pole de sante publique, Service d'information medicale, France.

Editorial

Linda Wittkop. Clin Infect Dis. 2016.

. 2016 Nov 1;63(9):1168-1170.

doi: 10.1093/cid/ciw537. Epub 2016 Aug 9.

¹ University of Bordeaux Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219- Bordeaux Population Health Centre Hospitalier Universitaire de Bordeaux, Pole de sante publique, Service d'information medicale, France.

No abstract available

Keywords: end-stage liver disease HIV; hepatitis B virus; hepatitis C virus.

Comment on

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Klein MB, et al. Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. doi: 10.1093/cid/ciw531. Epub 2016 Aug 9. Clin Infect Dis. 2016. PMID: 27506682 Free PMC article.